InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,272.50
(
-0.05%
)

Replies to post #77 on Kintara Therapeutics Inc (KTRA)

Replies to #77 on Kintara Therapeutics Inc (KTRA)

Rkmatters

12/28/15 11:03 AM

#78 RE: undtrdr #77

Yeah, it's retracing but it's oversold. Results are sold in my view. Patients have failed all therapies, and show extended survival in rGBM, in line with dosage escalation.